发明名称 中枢神経系疾患および心血管系疾患の標的であるカリウムチャネルタンパク質KCNQ5
摘要 <p>A DNA sequence (I) encoding: (i) a polypeptide (II) with KCNQ5 activity; (ii) a polypeptide with the amino acid (aa) sequence of KCNQ5; (iii) a fully defined sequence (S2) of 932 aa as given in the specification; or (iv) derivatives of S2 with one or more aa deletions or exchanges, is new. Independent claims are also included for the following: (1) proteins encoded by (I); (2) host cells containing at least one (I); and (3) screening assay for identifying compounds (A) that modulate the activity of (II). - ACTIVITY : Neurological; cardiovascular; anticonvulsant. - MECHANISM OF ACTION : Modulation of the voltage-dependent KCNQ5 potassium channel, a key regulator of membrane potential and modulator of excitability of electrically activated cells such as neurons and cardiomyocytes. KCNQ5 may be implicated in some forms of epilepsy.</p>
申请公布号 JP5622345(B2) 申请公布日期 2014.11.12
申请号 JP20010569011 申请日期 2001.03.13
申请人 发明人
分类号 C07K14/705;G01N33/50;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/12;C12P21/02;G01N33/15;G01N33/53;G01N33/566 主分类号 C07K14/705
代理机构 代理人
主权项
地址